Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
 

This article is part of the supplement: Symposium Mammographicum 2000

Meeting abstract

Radiological review of interval cancers in an Australian mammographic screening programme

J Cawson, AF Amos and AM Kavanagh and the Radiology Quality Assurance Group of BreastScreen Victoria

St. Vincent's BreastScreen, St. Vincent's Hospital, Melbourne, Australia

from Symposium Mammographicum 2000
York, UK. 4–6 October 2000

Breast Cancer Res 2000, 2(Suppl 2):A18doi:10.1186/bcr210

Published: 4 October 2000

© 2000 Current Science Ltd

Objectives

To determine the proportion and features of invasive interval cancers that could be detected at the time of screening and the proportion classified as true-intervals, false-negatives, minimal signs or radiographically occult lesions.

Setting

BreastScreen Victoria (Australia).

Methods

Review methodologies adopted: (1) a blinded review by five readers of interval, screen-detected and normal cases, followed by a confirmation exercise to determine the proportion detectable at the time of the previous screen; (2) an unblinded review to classify interval cases as true-interval, false-negative, minimal signs or radiographically occult.

Results

From the blinded review, 38% of interval cases were considered `potentially detectable' at screening. Comparison of interval and screen-detected cases shows that interval cases are more likely to be smaller, equivocal and ill-defined masses. In the unblinded exercise, 41% of interval cases were classified as false-negatives, 16% as minimal signs, 33% as true-intervals and 10% as radiographically occult.

Conclusions

This highlights the importance of adopting staged review methods with blinded and unblinded components. The blinded review and confirmation exercise determines the proportion of interval cases that were detectable at screening. The unblinded review provides an opportunity for professional development and links into the blinded review through further classification of interval cases.

Have something to say? Post a comment on this article!


© 1999-2008 BioMed Central Ltd unless otherwise stated < info@breast-cancer-research.com >   Terms and conditions